Skip to content

Clinical trials

Recruiting Phase 1/2 Leukemia, Lymphocytic, Chronic, B-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 1/2 Status: Recruiting Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20182
20191
20203
20213
20221
20233
20244
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
BeOne Medicines2
AVM Biotechnology Inc1
Ascentage Pharma Group Inc.1
BeiGene1
CRISPR Therapeutics AG1
Guangzhou Lupeng Pharmaceutical Company LTD.1
IDP Discovery Pharma S.L.1
Inhye Ahn1
Jeanette Lundin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell24
Lymphoma, Mantle-Cell11
Lymphoma, Follicular9
Lymphoma, Large B-Cell, Diffuse8
Lymphoma, Non-Hodgkin7
Lymphoma5
Lymphoma, B-Cell5
Lymphoma, B-Cell, Marginal Zone5
Leukemia4
Leukemia, B-Cell4

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.